Research and Markets: Global Steatohepatitis Clinical Trials Review 2015

Research and Markets (http://www.researchandmarkets.com/research/zgxkzh/steatohepatitis) has announced the addition of the "Steatohepatitis Global Clinical Trials Review, H1, 2015" report to their offering.

This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Steatohepatitis.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Clinical Trial Overview of Top Companies

• Genextra S.p.a.
• Galmed International Ltd.
• Raptor Pharmaceuticals Corp.
• Immuron Limited
• Genfit SA
• Cempra, Inc.
• Phenex Pharmaceuticals AG
• Gilead Sciences, Inc.
• F. Hoffmann-La Roche Ltd.
• Catalysis, S.L.

Clinical Trial Overview of Top Institutes / Government

• The National Institute of Diabetes and Digestive and Kidney Diseases
• Tehran University of Medical Sciences
• University of California, San Diego
• Hadassah Medical Organization
• Yokohama City University
• Institute of Liver and Biliary Sciences
• National Nutrition and Food Technology Research Institute
• University Health Network
• U.S. Department of Veterans Affairs
• University of Michigan

For more information visit http://www.researchandmarkets.com/research/zgxkzh/steatohepatitis